EICHORCondition: Amyotrophic Lateral Sclerosis (ALS) · Amyotrophic Lateral Sclerosis · Sponsor: Brainstorm-Cell Therapeutics
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The goal of this two-part clinical trial is: 1\) to evaluate the safety and efficacy of Debamestrocel - MSC-NTF (NurOwn) compared to placebo in participants with early symptomatic ALS and moderate disease presentation in ALS; followed by 2) further evaluation by providing NurOwn to all participants in an open label extension period. Researchers will compare NurOwn to a placebo (a look-alike substance that contains no drug) to evaluate the efficacy of NurOwn compared to placebo in the treatment of participants with ALS. Participants will: Receive NurOwn or a placebo every 8 weeks for 24 weeks. After that, every participant will receive NurOwn every 8 weeks for an additional 24 weeks. They will visit the clinic approximately every 8 weeks for checkups and tests.
This description comes directly from the study's public registry record.
Chief Medical Officer, Brainstorm Cell Therapeutics, MD · 201-488-0460 · ClinicalTrial@Brainstorm-cell.com
Always discuss trial participation with your own doctor first.
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| University of California San Diego Medical Center | La Jolla, California, United States | — |
| University of Southern California | Los Angeles, California, United States | — |
| California Pacific Medical Center | San Francisco, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| University of Colorado Anschutz Medical Campus School of Medicine | Aurora, Colorado, United States | — |
| Nova Southeastern University | Davie, Florida, United States | — |
| Mayo Clinic | Jacksonville, Florida, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
| Northwestern Medicine | Chicago, Illinois, United States | — |
| Sean M. Healey & AMG Center For ALS At Massachusetts General Hospital | Boston, Massachusetts, United States | — |
| University of Massachusetts Medical School | Worcester, Massachusetts, United States | — |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06973629